Maximal cardiac output determines 6 minutes walking distance in pulmonary hypertension
- PMID: 24647561
- PMCID: PMC3960234
- DOI: 10.1371/journal.pone.0092324
Maximal cardiac output determines 6 minutes walking distance in pulmonary hypertension
Abstract
Purpose: The 6 minutes walk test (6MWT) is often shown to be the best predictor of mortality in pulmonary hypertension (PH) probably because it challenges the failing heart to deliver adequate cardiac output. We hypothesised that the 6MWT elicits maximal cardiac output as measured during a maximal cardiopulmonary exercise testing (CPET).
Methods: 18 patients with chronic thromboembolic pulmonary hypertension (n = 12) or pulmonary arterial hypertension (n = 6) and 10 healthy subjects performed a 6MWT and CPET with measurements of cardiac output (non invasive rebreathing device) before and directly after exercise. Heart rate was measured during 6MWT with a cardiofrequence meter.
Results: Cardiac output and heart rate measured at the end of the 6MWT were linearly related to 6MW distance (mean±SD: 490±87 m). Patients with a high NT-pro-BNP achieve a maximum cardiac output during the 6MWT, while in normal subjects and in patients with a low-normal NT-proBNP, cardiac output at the end of a 6MWT was lower than achieved at maximum exercise during a CPET. In both cases, heart rate is the major determinant of exercise-induced increase in cardiac output. However, stroke volume increased during CPET in healthy subjects, not in PH patients.
Conclusion: Maximal cardiac output is elicited by 6MWT in PH patients with failing right ventricle. Cardiac output increase is dependent on chronotropic response in patients with PH.
Conflict of interest statement
Figures






Similar articles
-
Associations of Exercise Tolerance With Hemodynamic Parameters for Pulmonary Arterial Hypertension and for Chronic Thromboembolic Pulmonary Hypertension.J Cardiopulm Rehabil Prev. 2017 Sep;37(5):341-346. doi: 10.1097/HCR.0000000000000257. J Cardiopulm Rehabil Prev. 2017. PMID: 28671932
-
Clinical correlation between the 6-min walk test andcardiopulmonary exercise testing in patients with pulmonary arterial hypertension.Turk J Med Sci. 2016 Dec 20;46(6):1658-1664. doi: 10.3906/sag-1505-96. Turk J Med Sci. 2016. PMID: 28081353
-
A more effective alternative to the 6-minute walk test for the assessment of functional capacity in patients with pulmonary hypertension.Eur J Phys Rehabil Med. 2021 Aug;57(4):645-652. doi: 10.23736/S1973-9087.21.06561-8. Epub 2021 Feb 23. Eur J Phys Rehabil Med. 2021. PMID: 33619942 Clinical Trial.
-
Six-Minute Walk Test: How to do Guide for Performing a Reliable Test, Interpretation, and Prognostication in Pulmonary Hypertension.Turk Kardiyol Dern Ars. 2023 Oct;51(7):516-520. doi: 10.5543/tkda.2023.52279. Turk Kardiyol Dern Ars. 2023. PMID: 37861263 Review. English.
-
[Evaluation of exercise capacity in pulmonary arterial hypertension].Turk Kardiyol Dern Ars. 2010 Dec;38(8):580-8. Turk Kardiyol Dern Ars. 2010. PMID: 21248462 Review. Turkish.
Cited by
-
Guideline implementation and early risk assessment in pulmonary arterial hypertension associated with congenital heart disease: A retrospective cohort study.Clin Respir J. 2019 Nov;13(11):693-699. doi: 10.1111/crj.13076. Epub 2019 Aug 29. Clin Respir J. 2019. PMID: 31419027 Free PMC article.
-
Association between six-minute walk distance and long-term outcomes in patients with pulmonary arterial hypertension: Data from the randomized SERAPHIN trial.PLoS One. 2018 Mar 28;13(3):e0193226. doi: 10.1371/journal.pone.0193226. eCollection 2018. PLoS One. 2018. PMID: 29590122 Free PMC article. Clinical Trial.
-
Management of pulmonary hypertension due to heart failure with preserved ejection fraction.Curr Hypertens Rep. 2014 Dec;16(12):501. doi: 10.1007/s11906-014-0501-5. Curr Hypertens Rep. 2014. PMID: 25320018 Review.
-
Modulation of left ventricular diastolic filling during exercise in persons with cervical motor incomplete spinal cord injury.Eur J Appl Physiol. 2019 Dec;119(11-12):2435-2447. doi: 10.1007/s00421-019-04249-9. Epub 2019 Nov 7. Eur J Appl Physiol. 2019. PMID: 31701273 Free PMC article.
-
The incremental shuttle walk test predicts mortality in non-group 1 pulmonary hypertension: results from the ASPIRE Registry.Pulm Circ. 2019 Apr-Jun;9(2):2045894019848649. doi: 10.1177/2045894019848649. Pulm Circ. 2019. PMID: 30997865 Free PMC article.
References
-
- Hoeper MM, Bogaard HJ, Condliffe R, Frantz R, Khanna D, et al. (2013) Definitions and diagnosis of pulmonary hypertension. J Am Coll Cardiol 62: D42–50. - PubMed
-
- Stringer W, Hansen J, Wasserman K (1997) Cardiac Output estimated non-invsively from oxygen uptake (VO2) during exercise. J Appl Physiol 1997 82: 908–912. - PubMed
-
- Naeije R (2010) The 6-min walk distance in pulmonary arterial hypertension: “Je t'aime, moi non plus”. Chest 137: 1258–60. - PubMed
-
- Mainguy V, Malenfant S, Neyron AS, Bonnet S, Maltais F, et al. (2013) Repeatability and responsiveness of exercise tests in pulmonary arterial hypertension. Eur Resp J 42: 425–434. - PubMed
-
- Sitbon O, Humbert M, Nunes H, Parent F, Garcia G, et al. (2002) Long-term intravenous epoprostenol infusion in primary pulmonary hypertension: prognostic factors and survival. J Am Coll Cardiol. 40: 780–788. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials